Technical Analysis for HLN - Haleon plc

Grade Last Price % Change Price Change
B 8.27 0.92% 0.08
HLN closed down 1.68 percent on Wednesday, May 8, 2024, on approximately normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
2 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Flat Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.92%
Fell Below 200 DMA Bearish 0.92%
Fell Below 50 DMA Bearish 0.92%
Crossed Above 20 DMA Bullish -0.78%
Crossed Above 50 DMA Bullish -0.78%
Inside Day Range Contraction -0.78%
Gapped Up Strength -0.78%
50 DMA Resistance Bearish 0.30%
Fell Below 20 DMA Bearish 0.30%
MACD Bearish Signal Line Cross Bearish 0.30%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High 39 minutes ago
50 DMA Resistance 39 minutes ago
Rose Above 20 DMA about 1 hour ago
Gap Up Partially Closed about 2 hours ago
Gapped Up (Partial) about 2 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements. Its portfolio of brands include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was incorporated in 2021 and is headquartered in Brentford, the United Kingdom.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic

Is HLN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 8.82
52 Week Low 7.5997
Average Volume 6,874,862
200-Day Moving Average 8.21
50-Day Moving Average 8.31
20-Day Moving Average 8.28
10-Day Moving Average 8.36
Average True Range 0.14
RSI (14) 44.44
ADX 11.83
+DI 20.61
-DI 31.38
Chandelier Exit (Long, 3 ATRs) 8.21
Chandelier Exit (Short, 3 ATRs) 8.42
Upper Bollinger Bands 8.56
Lower Bollinger Band 7.99
Percent B (%b) 0.35
BandWidth 6.92
MACD Line 0.01
MACD Signal Line 0.02
MACD Histogram -0.012
Fundamentals Value
Market Cap 37.82 Billion
Num Shares 4.62 Billion
EPS 0.34
Price-to-Earnings (P/E) Ratio 24.09
Price-to-Sales 3.33
Price-to-Book 1.81
PEG Ratio 1.59
Dividend 0.02
Dividend Yield 0.24%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 8.48
Resistance 3 (R3) 8.48 8.40 8.43
Resistance 2 (R2) 8.40 8.32 8.39 8.41
Resistance 1 (R1) 8.29 8.28 8.25 8.29 8.40
Pivot Point 8.21 8.21 8.19 8.20 8.21
Support 1 (S1) 8.10 8.13 8.06 8.10 7.98
Support 2 (S2) 8.02 8.09 8.01 7.97
Support 3 (S3) 7.91 8.02 7.95
Support 4 (S4) 7.91